Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Servier Offers $483 Million To Buy Rest Of Hungarian Generics Maker Egis

Sep 24 2013

• By John Davis

Related Content

Korea's Celltrion Signs Deal with Hungary's Egis Pharmaceuticals to Sell Biosimilars In Former Soviet Republic Countries, Eastern Europe

Feb 08 2010

Double-Jointed Partnership With Servier Could Jumpstart Amgen’s CV Portfolio

Jul 11 2013

Related Companies

Les Laboratoires Servier

Egis Pharmaceuticals PLC

Celltrion, Inc.

Hospira, Inc.

Johnson & Johnson

Amgen, Inc.

Additional Topics

Europe Deals BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window